Enzymatic processing by MMP-2 and MMP-9 of wild-type and mutated mouse β-dystroglycan

IUBMB Life

Volumn 64, Issue 12, 2012, Pages 988-994

  Sbardella, Diego ^a,b   Inzitari, Rosanna ^c,f   Iavarone, Federica ^c   Gioia, Magda ^a,b   Marini, Stefano ^a,b   Sciandra, Francesca ^d   Castagnola, Massimo ^c   Van Den Steen, Philippe E ^e   Opdenakker, Ghislain ^e   Giardina, Bruno ^c   Brancaccio, Andrea ^d   Coletta, Massimo ^a,b   Bozzi, Manuela ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CIRCMSB ^*  (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d CNR   (Italy)

^e REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^f Java Clinical Research Ltd   (Ireland)

Author keywords

dystroglycan; kinetic; mass spectrometry; MMP 2; MMP 9

Indexed keywords

AMINO ACID; BETA DYSTROGLYCAN; DYSTROGLYCAN; GELATINASE; GELATINASE A; GELATINASE B; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COLLISIONALLY ACTIVATED DISSOCIATION; CONTROLLED STUDY; CYTOSKELETON; DEGRADATION KINETICS; ELECTROSPRAY MASS SPECTROMETRY; ENZYME DEGRADATION; ENZYME KINETICS; EXTRACELLULAR MATRIX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSECT CELL; MASS SPECTROMETRY; MOLECULAR WEIGHT; MUTANT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; ANIMALS; BACULOVIRIDAE; DYSTROGLYCANS; ESCHERICHIA COLI; KINETICS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE FRAGMENTS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEOLYSIS; RECOMBINANT PROTEINS; SF9 CELLS;

MURINAE;

EID: 84870211825     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1095     Document Type: Article

References (29)

1. Ibraghimov-Beskrovnaya, O., Ervasti, J. M., Leveille, C. J., Slaughter, C. A., Sernett, S. W., et al. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696-702.
2. Bozzi, M., Morlacchi, S., Bigotti, M. G., Sciandra, F., and, Brancaccio, A., (2009) Functional diversity of dystroglycan. Matrix Biol. 28, 179-187.
3. Henry, M. D., and, Campbell, K. P., (1999) Dystroglycan inside and out. Curr. Opin. Cell Biol. 11, 602-607. (Pubitemid 29460402)
4. Barresi, R., and, Campbell, K. P., (2006) Dystroglycan: from biosynthesis to pathogenesis of human disease. J. Cell Sci. 119, 199-207. (Pubitemid 43210689)
5. Court, F. A., Zambroni, D., Pavoni, E., Colombelli, C., Baragli, C., et al. (2011) MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains. J. Neurosci. 31, 12208-12217.
6. Sgambato, A., and, Brancaccio, A., (2005) The dystroglycan complex: from biology to cancer. J. Cell Physiol. 205, 163-169. (Pubitemid 41428897)
7. Agrawal, S., Anderson, P., Durbeej, M., van Rooijen, N., Ivars, F., et al. (2006) Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J. Exp. Med. 203, 1007-1019.
8. Michaluk, P., Kolodziej, L., Mioduszewska, B., Wilczynski, G. M., Dzwonek, J., et al. (2007) β-Dystroglycan as a target for MMP-9, in response to enhanced neuronal activity. J. Biol. Chem. 282, 16036-16041. (Pubitemid 47100368)
9. Zhao, X. L., Li, G. Z., Sun, B., Zhang, Z. L., Yin, Y. H., et al. (2010) MMP-mediated cleavage of β-dystroglycan in myelin sheath is involved in autoimmune neuritis. Biochem. Biophys. Res. Commun. 392, 551-556.
10. Losasso, C., Di Tommaso, F., Sgambato, A., Ardito, R., Cittadini, A., et al. (2000) Anomalous dystroglycan in carcinoma cell lines. FEBS Lett. 484, 194-198.
11. Zhong, D., Saito, F., Saito, Y., Nakamura, A., Shimizu, T., et al. (2006) Characterization of the protease activity that cleaves the extracellular domain of β-dystroglycan. Biochem. Biophys. Res. Commun. 345, 867-871. (Pubitemid 43776974)
12. Nagase, H., and, Woessner, J. F., Jr., (1999) Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494.
13. Van den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., et al. (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37, 375-536. (Pubitemid 36071972)
14. Li, H., Mittal, A., Makonchuk, D. Y., Bhatnagar, S., and, Kumar, A., (2009) Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum. Mol. Genet. 18, 2584-2598.
15. Sbardella, D., Fasciglione, G. F., Gioia, M., Ciaccio, C., Tundo, G. R., et al. (2012) Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. Mol. Aspects Med. 33, 119-208.
16. Björklund, M., and, Koivunen, E., (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim. Biophys. Acta 1755, 37-69. (Pubitemid 40720240)
17. Bozzi, M., Inzitari, R., Sbardella, D., Monaco, S., Pavoni, E., et al. (2009) Enzymatic processing of β-dystroglycan recombinant ectodomain by MMP-9: identification of the main cleavage site. IUBMB Life 61, 1143-1152.
18. Bozzi, M., Veglia, G., Paci, M., Sciandra, F., Giardina, B., et al. (2001) A synthetic peptide corresponding to the 550-585 region of α-dystroglycan binds β-dystroglycan as revealed by NMR spectroscopy. FEBS Lett. 499, 210-214. (Pubitemid 32553866)
19. Bozzi, M., Sciandra, F., Ferri, L., Torreri, P., Pavoni, E., et al. (2006) Concerted mutation of Phe residues belonging to the β-dystroglycan ectodomain strongly inhibits the interaction with α-dystroglycan in vitro. FEBS J. 273, 4929-4943. (Pubitemid 44583516)
20. Di Stasio, E., Sciandra, F., Maras, B., Di Tommaso, F., Petrucci, T. C., et al. (1999) Structural and functional analysis of the N-terminal extracellular region of β-dystroglycan. Biochem. Biophys. Res. Commun. 266, 274-278. (Pubitemid 30028804)
21. Van den Steen, P. E., Van Aelst, I., Hvidberg, V., Piccard, H., Fiten, P., et al. (2006) The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability by inhibition and binding to cargo receptors. J. Biol. Chem. 281, 18626-18637. (Pubitemid 44035522)
22. Gioia, M., Monaco, S., Fasciglione, G. F., Coletti, A., Modesti, A., et al. (2007) Characterization of the mechanism by which gelatinase A, neutrophil collagenase and membrane-type metalloproteinase MMP-14 recognize collagen I and enzymatically process the two α-chains. J. Mol. Biol. 368, 1101-1113. (Pubitemid 46574666)
23. Gioia, M., Monaco, S., Van den Steen, P. E., Sbardella, D., Grasso, G., et al. (2009) The collagen binding domain of gelatinase A modulates degradation of collagen IV by gelatinase B. J. Mol. Biol. 386, 419-434.
24. Ong, S. E., and, Mann, M., (2005) Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1, 252-262.
25. Van den Steen, P. E., Proost, P., Grillet, B., Brand, D. D., Kang, A. H., et al. (2002) Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 16, 379-389. (Pubitemid 34195299)
26. Chen, E. I., Li, W., Godzik, A., Howard, E. W., and, Smith, J. W., (2003) A residue in the S2 subsite controls substrate selectivity of matrix metalloproteinase-2 and matrix metalloproteinase-9. J. Biol. Chem. 278, 17158-17163. (Pubitemid 36799594)
27. Overall, C. M., and, Butler, G. S., (2007) Protease yoga: extreme flexibility of a matrix metalloproteinase. Structure 15, 1159-1161. (Pubitemid 47539171)
28. Rosenblum, G., Van den Steeen, P. E., Cohen, S. R., Grossmann, J. G., Frenkel, J., et al. (2007) Insight into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B. Structure 15, 1227-1236. (Pubitemid 47539163)
29. Moore, C. J., and, Winder, S. J., (2010) Dystroglycan versatility in cell adhesion: a tale of multiple motifs. Cell Commun. Signal. 8, 3-14.